Aravive Inc (DELISTED) (ARAV:DL)
0.0401
0.00 (0.00%)
USD |
NASDAQ |
Feb 07, 16:00
Aravive Cash from Operations (TTM): -59.45M for Sept. 30, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
September 30, 2023 | -59.45M |
June 30, 2023 | -68.58M |
March 31, 2023 | -69.94M |
December 31, 2022 | -65.08M |
September 30, 2022 | -59.19M |
June 30, 2022 | -48.92M |
March 31, 2022 | -35.05M |
December 31, 2021 | -32.18M |
September 30, 2021 | -19.61M |
June 30, 2021 | -17.24M |
March 31, 2021 | -17.73M |
December 31, 2020 | -12.17M |
September 30, 2020 | -21.46M |
June 30, 2020 | -18.57M |
March 31, 2020 | -20.15M |
December 31, 2019 | -17.08M |
September 30, 2019 | -20.79M |
June 30, 2019 | -22.57M |
March 31, 2019 | -22.64M |
December 31, 2018 | -29.26M |
Date | Value |
---|---|
September 30, 2018 | -57.48M |
June 30, 2018 | -74.78M |
March 31, 2018 | -89.57M |
December 31, 2017 | -116.29M |
September 30, 2017 | -97.92M |
June 30, 2017 | -52.54M |
March 31, 2017 | -54.31M |
December 31, 2016 | -40.63M |
September 30, 2016 | -38.14M |
June 30, 2016 | -77.74M |
March 31, 2016 | -69.59M |
December 31, 2015 | -69.06M |
September 30, 2015 | -63.96M |
June 30, 2015 | -58.38M |
March 31, 2015 | -54.37M |
December 31, 2014 | -39.65M |
September 30, 2014 | -33.27M |
June 30, 2014 | -27.41M |
March 31, 2014 | -18.19M |
December 31, 2013 | -17.09M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-69.94M
Minimum
Mar 2023
-12.17M
Maximum
Dec 2020
-34.76M
Average
-22.02M
Median
Cash from Operations (TTM) Benchmarks
Esperion Therapeutics Inc | -135.49M |
Processa Pharmaceuticals Inc | -8.063M |
NovaBay Pharmaceuticals Inc | -4.131M |
Palatin Technologies Inc | -26.54M |
iBio Inc | -18.89M |